HLB Genex, Inc.
HLB Genex, founded in 2000 and KOSDAQ-listed in 2015, develops custom enzymes and biohealthcare materials.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2000 and listed on KOSDAQ in 2015, HLB Genex specializes in custom enzymes and biohealthcare materials. It produces the hydrogen-peroxide-degrading enzyme catalase (Katalase™) and lactase (Lactazyme B™) among industrial specialty enzymes, along with biohealthcare materials including phytosphingosine, vitamin K2, and nattokinase, while its subsidiary HLB Neurotob is developing the dystonia treatment NT-1 and the Parkinson's disease treatment NT-3, both in preclinical stage. Based on its microbial display technology and recombinant protein secretion/expression technology, it became a KOSDAQ technology-special-listed company in 2015 through a technology assessment, and receives guidance from a technical advisory committee comprising experts from Gyeongsang National University, Kyungpook National University, and the Korea Research Institute of Bioscience and Biotechnology.
Key disclosures
KRX KIND via OpenDARTPatents
KIPRIS · applicant-matchedPCT · Published · 2025-11 · Application PCT/KR2025/018225
Published · 2025-11 · Application 1020250166707
PCT · Published · 2025-02 · Application PCT/KR2025/002723
Published · 2025-01 · Application 1020250012803
Published · 2024-10 · Application 1020240151610
- Subsidiary: 주식회사 지에프퍼멘텍아세틸화 파이토스핑고신 생산능이 향상된 재조합 미생물 및 이를 이용한 스핑고이드 또는 스핑고지질의 생산 방법
Registered · 2024-09 · Application 1020240121904
Registered · 2024-02 · Application 1020240029597
Registered · 2023-12 · Application 1020230174533
Registered · 2023-10 · Application 1020230138063
US · Published · 2023-09 · Application 19107564
Show 78 more patents
EP · Published · 2023-09 · Application 23860955.6
Registered · 2023-09 · Application 1020230116553
Rejected · 2023-05 · Application 1020230058794
- Subsidiary: 주식회사 지에프퍼멘텍COMPOSITION COMPRISING EXTRACT FROM CELL MASS OF BACILLUS SUBTILIS NATTO FOR IMPROVING MEMORY
PCT · Published · 2022-09 · Application PCT/KR2022/013780
Registered · 2022-07 · Application 1020220092639
Registered · 2022-07 · Application 1020220089592
Registered · 2022-05 · Application 1020220059871
Registered · 2022-05 · Application 1020220059864
Registered · 2022-05 · Application 1020220059872
Registered · 2022-05 · Application 1020220059870
Withdrawn · 2022-04 · Application 1020220047204
- Subsidiary: 주식회사 지에프퍼멘텍미생물 발효에 의한 테트라아세틸파이토스핑고신 생산 공정을 제어하는 방법 및 장치
Registered · 2022-03 · Application 1020220038437
- Subsidiary: 주식회사 지에프퍼멘텍락토바실러스 카제이를 포함하는 장면역 기능 증진용 조성물
Registered · 2022-03 · Application 1020220027911
Registered · 2021-11 · Application 1020210162690
- Subsidiary: 주식회사 지에프퍼멘텍미생물 발효에 의한 Proteinase K 생산 공정을 제어하는 방법 및 장치
Registered · 2021-11 · Application 1020210155979
- Subsidiary: 주식회사 지에프퍼멘텍바실러스 서브틸리스 낫또 배양균체 추출물을 포함하는 기억력 개선용 조성물
Registered · 2021-09 · Application 1020210124820
- Subsidiary: 주식회사 지에프퍼멘텍미생물 발효에 의한 단백질 생산 공정을 제어하는 방법 및 장치
Registered · 2021-07 · Application 1020210095195
Published · 2021-05 · Application 1020227042717
- Subsidiary: 주식회사 지에프퍼멘텍한국 전통 청국장에서 분리된 초고순도 트랜스형 메나퀴논-7 고생산능을 가지는 신규한 바실러스 서브틸리스 균주 및 이의 용도
Registered · 2020-10 · Application 1020200141938
Registered · 2020-08 · Application 1020200105682
- Subsidiary: 주식회사 지에프퍼멘텍Novel Bacillus sp. isolated from Korean Traditional Soy bean paste (Cheonggu paste) with high fibrinolytic enzyme productivity
CN · Published · 2020-04 · Application 202010356851.5
Registered · 2019-12 · Application 1020190160771
Registered · 2019-09 · Application 1020190108892
Registered · 2019-06 · Application 1020190068617
Rejected · 2019-04 · Application 1020190050779
Registered · 2019-04 · Application 1020190044706
Registered · 2018-09 · Application 1020180110980
Registered · 2018-09 · Application 1020180105592
- Subsidiary: 주식회사 지에프퍼멘텍바실러스 스브틸러스 균을 이용한 비타민 K2의 신규한 제조방법
Withdrawn · 2018-02 · Application 1020180022732
Registered · 2017-09 · Application 1020170116305
Registered · 2017-03 · Application 1020170030301
Registered · 2017-03 · Application 1020170030300
Registered · 2017-03 · Application 1020170028797
Registered · 2016-11 · Application 1020160151003
Registered · 2016-11 · Application 1020160151004
Rejected · 2016-02 · Application 1020160014033
Registered · 2015-11 · Application 1020150155773
Registered · 2015-07 · Application 1020150100592
Rejected · 2015-05 · Application 1020150074862
- Subsidiary: 주식회사 지에프퍼멘텍신규한 하이포마이크로비움속 미생물 및 이를 이용한 피로로퀴놀린 퀴논의 제조방법
Registered · 2014-12 · Application 1020140173838
Rejected · 2014-10 · Application 1020140136488
Rejected · 2014-05 · Application 1020140064550
Registered · 2014-05 · Application 1020140063980
Registered · 2014-05 · Application 1020140063977
Registered · 2014-05 · Application 1020140063976
Registered · 2014-05 · Application 1020140063979
Registered · 2014-05 · Application 1020140062392
Expired · 2014-04 · Application 1020140041664
Registered · 2013-10 · Application 1020130131770
Registered · 2013-10 · Application 1020130131771
Registered · 2013-10 · Application 1020130131769
Expired · 2013-05 · Application 1020130060038
Expired · 2013-05 · Application 1020130059272
- Subsidiary: 주식회사 지에프퍼멘텍신규한 류코노스톡 메센터로이드 KPX-14 및 이를 이용한 D형 유산을 생산하는 방법
Registered · 2012-12 · Application 1020120150840
- Subsidiary: 주식회사 지에프퍼멘텍신규한 바이셀라 헬레니카 KPX-17 및 이를 이용한 D형 유산을 생산하는 방법
Abandoned · 2012-12 · Application 1020120150896
Registered · 2009-12 · Application 1020090126350
Rejected · 2009-11 · Application 1020090111062
Rejected · 2009-11 · Application 1020090107762
Registered · 2009-02 · Application 1020090015489
Registered · 2009-02 · Application 1020090015491
Registered · 2009-02 · Application 1020090015490
- Subsidiary: 주식회사 지에프퍼멘텍스트렙토마이세스 그리세우스 변이주 및 이를 이용한 트립신 함량이 높은 프로네이즈 생산방법
Registered · 2008-09 · Application 1020080087361
Expired · 2007-11 · Application 1020070112490
Registered · 2007-10 · Application 1020070108998
- Subsidiary: 주식회사 지에프퍼멘텍바실러스 벨리스몰티스의 혈전용해 단백질을 함유한 구강위생 생산물
Expired · 2007-07 · Application 1020070073875
- Subsidiary: 주식회사 지에프퍼멘텍대장균에 의한 라이코펜의 대량 제조방법
Expired · 2006-02 · Application 1020060015489
Rejected · 2006-02 · Application 1020060011642
Rejected · 2006-01 · Application 1020060007412
Expired · 2003-09 · Application 1020030064998
Expired · 2003-05 · Application 1020030030426
Expired · 2002-07 · Application 1020020041206
Expired · 2002-06 · Application 1020020034418
- Subsidiary: 주식회사 지에프퍼멘텍재조합 단백질의 생산성 증가를 위한 재조합 효모의 배양방법
Expired · 2002-04 · Application 1020020020257
Expired · 2002-04 · Application 1020047016115
Expired · 2001-12 · Application 1020037007477
Abandoned · 2001-08 · Application 1020010047232
Expired · 2001-01 · Application 1020010002156
Withdrawn · 2000-12 · Application 1020000074835
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot6
- AnthropicClaudeBot2
- PerplexityPerplexityBot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 4 AI engines · last read Sep 29, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for HLB Genex, Inc. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition